Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer
Melek Akay, Jennifer Glendenning, Holly Tovey, et al.
NPJ Breast Cancer
|
April 8, 2022
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
Melinda L Telli, Sara M Tolaney, Geoffrey I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom
Susan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers
Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
Peter C Fong, Timothy A Yap, David S Boss, et al.
Nature Communications
|
May 31, 2020
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Neha Chopra, Holly Tovey, Alex Pearson, et al.
Cell Reports
|
May 16, 2019
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer
Rachel Evans, Fabian Flores-Borja, Sina Nassiri, et al.
BMC Cancer
|
November 26, 2008
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature
Andrew Tutt, Alice Wang, Charles Rowland, et al.
Molecular Cancer Therapeutics
|
November 15, 2017
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer
Kalnisha Naidoo, Patty T Wai, Sarah L Maguire, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer
Melek Akay, Jennifer Glendenning, Holly Tovey, et al.
NPJ Breast Cancer
|
April 8, 2022
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
Melinda L Telli, Sara M Tolaney, Geoffrey I Shapiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
Holly Tovey, Orsolya Sipos, Joel S Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom
Susan Shanley, Kate McReynolds, Audrey Ardern-Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers
Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2010
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
Peter C Fong, Timothy A Yap, David S Boss, et al.
Nature Communications
|
May 31, 2020
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Neha Chopra, Holly Tovey, Alex Pearson, et al.
Cell Reports
|
May 16, 2019
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer
Rachel Evans, Fabian Flores-Borja, Sina Nassiri, et al.
BMC Cancer
|
November 26, 2008
Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature
Andrew Tutt, Alice Wang, Charles Rowland, et al.
Molecular Cancer Therapeutics
|
November 15, 2017
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response-Targeted Therapies in Breast Cancer
Kalnisha Naidoo, Patty T Wai, Sarah L Maguire, et al.
Page
of 10